PROVIDER PROFILE · NPI 1992777627
Angelo MancusoDO
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,643
Unique beneficiaries
—
Total services
13,687
Distinct HCPCS
34
Medicare payment
$900K
Peer benchmark
Total Medicare services vs. 156 Dermatology providers in AL — top quintile (cohort median 2,926).
PRESCRIBING · PART D · 2024
Total Rx claims
933
Beneficiaries
—
Total drug cost
$80K
Distinct drugs
14
Brand share
28.2%
Top prescribed drugs
Ciclopirox Olamine183 claims
Fluocinonide102 claims
Hydrocortisone99 claims
Cephalexin86 claims
Clindamycin Phosphate86 claims
QUALITY · MIPS · 2024
Final MIPS score
0.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-9.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$96
Payment records
8
By payment type
Food and Beverage$96
Top paying entities
Food and Beverage$96
REFERRAL NETWORK
Where Angelo Mancuso's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| THE HEALTH CARE AUTHORITY OF THE CITY OF HUNTSVILLE | 129 | 392 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 60 | 168 |
| H H HEALTH SYSTEM-MORGAN LLC | 48 | 149 |
| RCHP - FLORENCE LLC | 31 | 97 |
| CRESTWOOD HEALTHCARE LP | 22 | 47 |
| Paul Fry Diagnostic Radiology · Huntsville, AL | 14 | 31 |
| Pathgroup Labs, Llc Clinical Laboratory · Nashville, TN | 12 | 30 |
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | 11 | 27 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE